Cargando…
Human osteopontin: Potential clinical applications in cancer (Review)
Human osteopontin (OPN) is a glycosylated phosphoprotein which is expressed in a variety of tissues in the body. In recent years, accumulating evidence has indicated that the aberrant expression of OPN is closely associated with tumourigensis, progression and most prominently with metastasis in seve...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428945/ https://www.ncbi.nlm.nih.gov/pubmed/28440483 http://dx.doi.org/10.3892/ijmm.2017.2964 |
_version_ | 1783235936304234496 |
---|---|
author | Hao, Chengcheng Cui, Yuxin Owen, Sionen Li, Wenbin Cheng, Shan Jiang, Wen G. |
author_facet | Hao, Chengcheng Cui, Yuxin Owen, Sionen Li, Wenbin Cheng, Shan Jiang, Wen G. |
author_sort | Hao, Chengcheng |
collection | PubMed |
description | Human osteopontin (OPN) is a glycosylated phosphoprotein which is expressed in a variety of tissues in the body. In recent years, accumulating evidence has indicated that the aberrant expression of OPN is closely associated with tumourigensis, progression and most prominently with metastasis in several tumour types. In this review, we present the current knowledge on the expression profiles of OPN and its main splice variants in human cancers, as well as the potential implications in patient outcome. We also discuss its putative clinical application as a cancer biomarker and as a therapeutic target. |
format | Online Article Text |
id | pubmed-5428945 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-54289452017-05-15 Human osteopontin: Potential clinical applications in cancer (Review) Hao, Chengcheng Cui, Yuxin Owen, Sionen Li, Wenbin Cheng, Shan Jiang, Wen G. Int J Mol Med Articles Human osteopontin (OPN) is a glycosylated phosphoprotein which is expressed in a variety of tissues in the body. In recent years, accumulating evidence has indicated that the aberrant expression of OPN is closely associated with tumourigensis, progression and most prominently with metastasis in several tumour types. In this review, we present the current knowledge on the expression profiles of OPN and its main splice variants in human cancers, as well as the potential implications in patient outcome. We also discuss its putative clinical application as a cancer biomarker and as a therapeutic target. D.A. Spandidos 2017-06 2017-04-21 /pmc/articles/PMC5428945/ /pubmed/28440483 http://dx.doi.org/10.3892/ijmm.2017.2964 Text en Copyright: © Hao et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Hao, Chengcheng Cui, Yuxin Owen, Sionen Li, Wenbin Cheng, Shan Jiang, Wen G. Human osteopontin: Potential clinical applications in cancer (Review) |
title | Human osteopontin: Potential clinical applications in cancer (Review) |
title_full | Human osteopontin: Potential clinical applications in cancer (Review) |
title_fullStr | Human osteopontin: Potential clinical applications in cancer (Review) |
title_full_unstemmed | Human osteopontin: Potential clinical applications in cancer (Review) |
title_short | Human osteopontin: Potential clinical applications in cancer (Review) |
title_sort | human osteopontin: potential clinical applications in cancer (review) |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428945/ https://www.ncbi.nlm.nih.gov/pubmed/28440483 http://dx.doi.org/10.3892/ijmm.2017.2964 |
work_keys_str_mv | AT haochengcheng humanosteopontinpotentialclinicalapplicationsincancerreview AT cuiyuxin humanosteopontinpotentialclinicalapplicationsincancerreview AT owensionen humanosteopontinpotentialclinicalapplicationsincancerreview AT liwenbin humanosteopontinpotentialclinicalapplicationsincancerreview AT chengshan humanosteopontinpotentialclinicalapplicationsincancerreview AT jiangweng humanosteopontinpotentialclinicalapplicationsincancerreview |